Skip to main content
TipRanks
Go Ultimate75% OFF

Rocket Pharmaceuticals (9IP1) Balance Sheet

2 Followers

Rocket Pharmaceuticals Balance Sheet

Rocket Pharmaceuticals's total assets for Q3 2026 were $419.50M, a decrease of 0.85% from the previous quarter. DE:9IP1 total liabilities were $92.78M for the fiscal quarter, a 70.97% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 330.45M$ 527.70M$ 566.34M$ 551.81M$ 497.02M
$ 53.23M$ 64.47M$ 73.77M$ 62.12M$ 42.30M
$ 277.22M$ 463.23M$ 492.57M$ 489.69M$ 454.72M

Currency in USD

Rocket Pharmaceuticals Liabilities to Assets

0250M500M750M0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets